~~<i id='844313D8D3'><strike id='844313D8D3'><tt id='844313D8D3'><pre id='844313D8D3'></pre></tt></strike></i>~~

Home» Wikipedia» comprehensive

comprehensive

author：fashion 2025-09-30 12:00:13 Page View：7

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Superbugs, antibiotic resistance get scrutiny in congress
Next article： Alkermes shareholders re

explore

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Women's World Cup brings attention to abuse in soccer

FILE-RepublicofIreland'sSineadFarrelly,center,greetsplayersaftertheteam'smatchwiththeUnitedStatesina

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Women's World Cup brings attention to abuse in soccer

FILE-RepublicofIreland'sSineadFarrelly,center,greetsplayersaftertheteam'smatchwiththeUnitedStatesina